1 This includes bullous pemphigoid and benign mucousmembrane ... Only 1 of the 30 patients was Jewish, unlike the pattern in pemphigus vulgaris, which appears to involve a relatively high ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced.

The Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Sanofi SNY and its partner, Regeneron REGN, announced that the FDA has approved their blockbuster medicine, Dupixent ...

Differentiation of PV from the other clinical variants of pemphigus, including pemphigus ... and/or skin lesions include herpes simplex, bullous pemphigoid, dermatitis herpetiformis, erythema ...

Blisters are small fluid-filled pockets that usually form as a result of friction, burns, or irritation, with tight shoes being one of the most common triggers. If you've ever found a painful bump ...

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

Bullous pemphigoid (BP), which has no FDA ... respectively. The International Pemphigus & Pemphigoid Foundation (IPPF) has hailed the results as a landmark for the BP patient community, whose ...

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with ...